About Us
Innovative Medical Devices
For China and Global Markets.Who We Are
MaxNova is a medical technology company that aims to improve healthcare outcomes by providing innovative medical solutions with an Open Innovation approach.
Strength & Area
MaxNova’s core strengths lie in our Open Innovation approach and our resources and capabilities for commercialization. We initially focus on neurological health, collaborating with industry partners, academic institutions, and medical professionals to develop innovative solutions. We provide the essential resources and capabilities needed for commercialization and successfully bringing our products to market.
Strength & Area
MaxNova’s core strengths lie in our Open Innovation approach and our resources and capabilities for commercialization. We initially focus on neurological health, collaborating with industry partners, academic institutions, and medical professionals to develop innovative solutions. We provide the essential resources and capabilities needed for commercialization and successfully bringing our products to market.
Background
Established in 2020 and headquartered in Hong Kong, MaxNova is powered by a dynamic team of healthcare professionals, engineers, and scientists who are passionate about translating advanced medical technologies into practical applications.
Background
Established in 2020 and headquartered in Hong Kong, MaxNova is powered by a dynamic team of healthcare professionals, engineers, and scientists who are passionate about translating advanced medical technologies into practical applications.
Our Mission
Through open innovation, we are dedicated to transforming cutting-edge medical technologies into accessible solutions, thereby improving the quality of life for patients around the world.
Problem
Our initial focus is on serving those affected by neurological disorders. As we move towards 2030, it is estimated that the population with neurological conditions in China will skyrocket to an unprecedented 250 million—this means that nearly one in every six individuals will be grappling with a neurological disease. The swift rise in such health issues represents a critical and formidable challenge to the national healthcare infrastructure.
Solution
At MaxNova, we confront this challenge head-on by adopting an Open Innovation approach to the creation of neurotech products. Our method involves fostering partnerships, encouraging localization, and facilitating commercialization. Our goal is not just to keep pace with the latest neurotech advancements but to transform these cutting-edge innovations into life-altering solutions for those battling neurological disorders.
Problem
Our initial focus is on serving those affected by neurological disorders. As we move towards 2030, it is estimated that the population with neurological conditions in China will skyrocket to an unprecedented 250 million—this means that nearly one in every six individuals will be grappling with a neurological disease. The swift rise in such health issues represents a critical and formidable challenge to the national healthcare infrastructure.
Solution
At MaxNova, we confront this challenge head-on by adopting an Open Innovation approach to the creation of neurotech products. Our method involves fostering partnerships, encouraging localization, and facilitating commercialization. Our goal is not just to keep pace with the latest neurotech advancements but to transform these cutting-edge innovations into life-altering solutions for those battling neurological disorders.
Why MaxNova
MaxNova was conceived and brought to life by a seasoned team of professionals, each boasting over a quarter-century of experience in the healthcare industry. This collective wealth of knowledge and proficiency forms the backbone of our operations. Situated in Hong Kong, a bustling global financial nexus, we are strategically positioned to secure sustainable capital funding for our ventures. Additionally, this location affords us access to well-established market resources, thus bolstering the growth and success of our enterprise.
Open Innovation Approach
MaxNova operates on the principle of Open Innovation, which encourages collaboration, knowledge sharing, and co-creation of value. By collaborating with MaxNova, your innovation will gain access to a wide network of experts, resources, and market insights, which can significantly accelerate the development and commercialization process.
Open Innovation Approach
MaxNova operates on the principle of Open Innovation, which encourages collaboration, knowledge sharing, and co-creation of value. By collaborating with MaxNova, your innovation will gain access to a wide network of experts, resources, and market insights, which can significantly accelerate the development and commercialization process.
Expertise in MedTech Products
MaxNova has a deep focus on medical technology solutions and has developed significant expertise in this sector. This specialized knowledge can be invaluable in tailoring your medical technology to address the unique challenges and opportunities in the healthcare market.
Expertise in MedTech Products
MaxNova has a deep focus on medical technology solutions and has developed significant expertise in this sector. This specialized knowledge can be invaluable in tailoring your medical technology to address the unique challenges and opportunities in the healthcare market.
Strong Commercialization Capabilities
MaxNova brings to the table a strong capacity for commercialization. The company has the resources, network, and strategic know-how to bring a product from the prototype stage to the market successfully. This ability can greatly enhance the chances of your innovative medical technology reaching its intended users and making a real impact.
Strong Commercialization Capabilities
MaxNova brings to the table a strong capacity for commercialization. The company has the resources, network, and strategic know-how to bring a product from the prototype stage to the market successfully. This ability can greatly enhance the chances of your innovative medical technology reaching its intended users and making a real impact.
Leadership
At the helm of our operations is a cadre of core executives, each an industry stalwart with a deep understanding of medical technologies and a wide breadth of experience spanning product development. We’ve assembled a global team tasked with the implementation of our Three-Step Solution, a strategy central to our mission of creating a positive impact on patients, communities, and the healthcare industry at large.
Executive Management
Strategic Investment
Capital Funding
Our forward-thinking investment strategy in the dynamic MedTech sector, combined with our proven expertise in building robust relationships with entrepreneurs, executives, and investors throughout the healthcare industry, plays a pivotal role in the success of our projects and the expansion of our partners.
We collaborate with premier venture capitalists and private equity funds with a focus on healthcare in the China and Asia markets. Our joint investments in today’s groundbreaking ideas aim to pave the way for a healthier tomorrow.
Strategic Investment
Capital Funding
Our forward-thinking investment strategy in the dynamic MedTech sector, combined with our proven expertise in building robust relationships with entrepreneurs, executives, and investors throughout the healthcare industry, plays a pivotal role in the success of our projects and the expansion of our partners.
We collaborate with premier venture capitalists and private equity funds with a focus on healthcare in the China and Asia markets. Our joint investments in today’s groundbreaking ideas aim to pave the way for a healthier tomorrow.
